atopica vet. 10 mg kapseli, pehmeä
elanco gmbh - ciclosporin - kapseli, pehmeä - 10 mg - siklosporiini
atopica vet. 25 mg kapseli, pehmeä
elanco gmbh - ciclosporin - kapseli, pehmeä - 25 mg - siklosporiini
atopica vet. 50 mg kapseli, pehmeä
elanco gmbh - ciclosporin - kapseli, pehmeä - 50 mg - siklosporiini
atopica vet. 100 mg kapseli, pehmeä
elanco gmbh - ciclosporin - kapseli, pehmeä - 100 mg - siklosporiini
atopica vet. 100 mg/ml oraaliliuos
elanco gmbh - ciclosporin - oraaliliuos - 100 mg/ml - siklosporiini
cibinqo
pfizer europe ma eeig - abrocitinib - dermatitis, atopic - muut dermatologiset valmisteet - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
dexatopic emulsiovoide
n.v. organon - nandroloni decanoas,dexamethasonum,chlorhexidini dihydrochloridum - emulsiovoide - deksametasoni
dexatopic voide
n.v. organon - chlorhexidini dihydrochloridum,nandroloni decanoas,dexamethasonum - voide - deksametasoni
dexatopic emulsiovoide
organon (ireland) limited - nandroloni decanoas,dexamethasonum,chlorhexidini dihydrochloridum - emulsiovoide - deksametasoni
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopic - muut dermatologiset valmisteet - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.